Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity
Completed · Phase 1
Conditions studied: HIV Prevention
In brief
Purpose of the study is to assess tenofovir (TFV) PK and PD endpoints, cervicovaginal safety parameters, susceptibility to HIV-1 infection, and objective measures of vaginal applicator use in premenopausal and postmenopausal women.
Key facts
- Study ID
- NCT01810315
- Run by
- CONRAD
- People needed
- 40
- Starts
- 2013-09-01
- Expected to finish
- 2014-10-01
- Last updated by the study team
- 2015-04-10
Who can join
Age: 21 and older, up to 89. Sex: female. Healthy volunteers: accepted.
Where it is running
- Clinical Research Center, Eastern Virginia Medical School — Norfolk, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.